肝病患者ALT、γ-GT、ChE组合试验分析

An analysis of Combined Test of Serum ALT,γ-GT, ChE Activity in 103 Hepatosis Patients

血清丙氨酸转氨酶（ＡＬＴ）、γ－谷氨酰转移酶（γ－ＧＴ）、胆碱酯酶（ＣｈＥ）三酶组合试验对１０３例肝病（分为肝炎、肝硬化、肝癌三组）患者的测定结果表明：组合试验对肝病的检出有较高的阳性率，肝炎组阳性率达８１３％，肝癌组阳性率达９１７％，肝硬化组阳性率达９６３％。在全部１０３例肝病中，组合试验的阳性率达８６４％，明显高于单一测定ＡＬＴ的５６３％，单一测定γ－ＧＴ的６４１％，单一测定ＣｈＥ的３５９％（均Ｐ＜００１）。故ＡＬＴ、γ－ＧＴ、ＣｈＥ三酶组合试验在肝疾病的筛检中有一定价值。

The results of the combined test of ALT , γ-GT, ChE in 103 patients (divided to three groups: hepatitis , hepatocirrhosis , hepatic cancer ) shown its positive ratiois singnificantly higher than that of test with each single enzyme. In hepatitis group , the combined positive ratio was 81.3%,hepatic cancer group 91.7% and hepatocirrhosis group 96.3%,respectively.In all of 103 patients of hepatosis,its positive ratio was 86.4%,and was higher than 56.3% of single ALT, 64.5% of single γ-GT, and 35.9% of single ChE (P<0.01,respectively). The combined test is thus considered with more value in screening hepatosis.